CDSCO notice, dated May 4, 2026, stated that long-pending applications on the SUGAM portal awaiting query response will be rejected. It directs all applicants to respond to regulatory queries within 30 days of issuance. The notice highlights that numerous applications...
Starting a drug manufacturing business in India in 2026 offers strong potential. Rising domestic demand, global export opportunities, and supportive government policies are the driving factors for this booming industry. However, success requires strict compliance with...
In this blog, we have given detailed insights into what is CDSCO, its role, divisions, and importance. Additionally, we have provided some common FAQs on CDSCO. What is CDSCO? The Central Drugs Standard Control Organisation (CDSCO) under the Directorate General of...
In this blog, we have discussed the advantages of having GMP certification for pharmaceutical companies. Additionally, we have presented the GMP certification mistakes to avoid and the challenges of maintaining certification. What is good manufacturing practices...
CDSCO is the apex regulatory body for medical devices, pharmaceuticals, and cosmetics entering the Indian market. All these products are regulated to ensure their safety and effectiveness as well as safeguard the patients and consumers. A CDSCO license is required to...
India has granted a customs duty waiver on 40 petrochemical inputs until June 30, 2026. The aim is to ease the burden on pharmaceutical and medical device manufacturers facing raw material price hikes due to the West Asia conflict. The waiver covers critical...